...
首页> 外文期刊>Cardiology Journal >The left and right ventricle of a patient with a R723G mutation of the beta-myosin heavy chain and severe hypertrophic cardiomyopathy show no differences in the expression of myosin mRNA
【24h】

The left and right ventricle of a patient with a R723G mutation of the beta-myosin heavy chain and severe hypertrophic cardiomyopathy show no differences in the expression of myosin mRNA

机译:β-肌球蛋白重链R723G突变和严重肥厚型心肌病患者的左,右心室肌球蛋白mRNA表达无差异

获取原文
   

获取外文期刊封面封底 >>

       

摘要

Background: In familial hypertrophic cardiomyopathy (FHC), asymmetric left ventricular (LV) hypertrophy has been considered to be the predominant phenotypic expression, whereas right ventricular (RV) involvement is still ambiguous. In most cases, the right ventricle remains unaffected until secondary pulmonary hypertension develops. Several FHC-causing mutations of genes encoding sarcomere-related proteins have been identified which are transmitted in an autosomal-dominant manner. Methods: We report the case of a 61 year old member of a Catalan family with a Arg723Gly missense mutation of the β-myosin heavy chain (β-MHC), that is associated with a malignant phenotype characterized by sudden cardiac death and heart failure. Because of progressive systolic LV dysfunction, the patient received a heart transplant in 2003. Results: Molecular analysis of the myocardial tissue of the explanted heart, taken from the left and right ventricle, showed a similar deviation of the ratio of mutant vs wild type mRNA of the β-MHC of 71.8 ± 5% and 68.5 ± 3%, respectively. This finding was confirmed for LV biopsies of this patient on protein level, showing a similar proportion of mutated β-myosin. But since the patient is heterozygous for the β-MHC mutation and the mutation is located in a coding region, the relative increase of the expression of the mutant allele is unexpected. It has been demonstrated before by our group for several β-MHC mutations that the relative abundance of mutated mRNA/protein correlates with the clinical severity of the disease. But since the right ventricle shows no (or only minor) manifestation in terms of hypertrophy or dysfunction, the level of mRNA and protein expression is not the only factor responsible for the development of the phenotype of FHC. Conclusions: Several mechanisms through which cardiac stresses may incite maladaptive cardiac remodeling primarily of the left ventricle that result in myocardial hypertrophy and heart failure are proposed. One of those triggers could be the enhanced work load of the left ventricle, especially if a LV outflow tract gradient is present, in contrast to the lesser demands to the right ventricle which is adapted to the low pressure system of the pulmonary circulation. Further studies are needed to confirm the results of this case, as well as functional studies involving both ventricles. (Cardiol J 2010; 17, 5: 518-522)
机译:背景:在家族性肥厚型心肌病(FHC)中,不对称的左心室(LV)肥大被认为是主要的表型表达,而右心室(RV)的参与仍然不明确。在大多数情况下,直到发生继发性肺动脉高压之前,右心室仍不受影响。已经鉴定出几种引起FHC突变的编码肌节相关蛋白的基因,这些突变以常染色体显性方式传播。方法:我们报道了一个加泰罗尼亚家庭的一名61岁成员,该患者患有β-肌球蛋白重链(β-MHC)的Arg723Gly错义突变,该突变与特征在于心脏猝死和心力衰竭的恶性表型有关。由于进行性收缩期左室功能不全,该患者于2003年接受了心脏移植。结果:从左心室和右心室进行的离体心脏心肌组织的分子分析显示,突变型与野生型mRNA的比率存在相似的偏差β-MHC分别为71.8±5%和68.5±3%。对该患者的LV活检在蛋白质水平上证实了这一发现,显示出类似比例的突变的β-肌球蛋白。但是由于患者对β-MHC突变是杂合的,并且突变位于编码区,因此突变等位基因表达的相对增加是出乎意料的。我们的小组之前已经证明了一些β-MHC突变,即突变的mRNA /蛋白质的相对丰度与疾病的临床严重程度有关。但是由于在肥大或功能障碍方面右心室没有(或仅有少量)表现,因此mRNA和蛋白质表达的水平不是造成FHC表型发展的唯一因素。结论:提出了几种机制,通过这些机制,心脏压力可引起主要是左心室适应不良的心脏重塑,从而导致心肌肥大和心力衰竭。这些触发因素之一可能是左心室的工作负荷增加,特别是如果存在左室流出道梯度时,与适应肺循环低压系统的对右心室的需求减少相比,这种变化尤其明显。需要进一步的研究以确认该病例的结果,以及涉及两个心室的功能研究。 (Cardiol J 2010; 17,5:518-522)

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号